Research

Our vision for 21st century science emerges from complementary strengths in drug discovery and development, preclinical imaging, proteomics, cell free synthesis, physiochemical analysis, and nanoscale imaging. The next waves of technology for early detection and treatment of a broad array of diseases will arise from this multi-pronged attack.

Transforming Science. Transforming Life.

Chemistry of Life Processes Institute (CLP) researchers use the technologies of tomorrow to discover the diagnostic methods and therapies needed to save lives today. Chemists, engineers, and physicists team with life scientists and clinicians to change how we diagnose and treat cancer, cardiovascular and kidney disease, infectious diseases, neurodegenerative diseases, and trauma. Their efforts are built on extraordinary tools for discovery, analysis, and visualization developed and housed within a unique ecosystem designed to support the integration of expertise and methods across many scientific disciplines. This transdisciplinary convergence of knowledge is creating new fields of research that will have a long-lasting impact on human health and disease.

Transforming Science. Transforming Life.

Chemistry of Life Processes Institute (CLP) researchers use the technologies of tomorrow to discover the diagnostic methods and therapies needed to save lives today. Chemists, engineers, and physicists team with life scientists and clinicians to change how we diagnose and treat cancer, cardiovascular and kidney disease, infectious diseases, neurodegenerative diseases, and trauma. Their efforts are built on extraordinary tools for discovery, analysis, and visualization developed and housed within a unique ecosystem designed to support the integration of expertise and methods across many scientific disciplines. This transdisciplinary convergence of knowledge is creating new fields of research that will have a long-lasting impact on human health and disease.

Original article published on Northwestern Now­. Written by Marla Paul Patients with Huntington’s disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population. Northwestern...

Original article published on Northwestern Engineering News. Written by Amanda Morris. Biologists have long understood the various parts within the cell. But how these parts interact with and respond to each other is largely unknown. “We want to understand how cells...

Article originally published on Northwestern Engineering News. Written by Amanda Morris Nanocarriers are one of the most promising forms of targeted drug delivery. They can be programmed to selectively target cancer and other sites of disease. For instance, in cancer,...

Originally posted on Northwestern Medicine News Center. Written by Will Doss In two recent publications, Northwestern Medicine scientists and international collaborators discovered mutations that cause improper drainage and a buildup of ocular pressure leading to one...

Northwestern investigator John Rogers developed a wireless device that enables realistic behavioral studies using a powerful emerging technique, optogenetic stimulation, which targets specific neuronal populations and regulates their activity using light.